Zomedica (ZOMDF) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Zomedica Corp   (NONE: ZOMDF)
 

Zomedica Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Zomedica Corp inventory turnover ratio, the Zomedica Corp 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.05 in the second quarter 2026, a new company high. Average inventory processing period, for the Zomedica in Jun 30 2026 quarter, has decreased to 178 days, compare to 195 days, in the Mar 31 2026 quarter.

Within Healthcare sector 197 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1237 in the first quarter 2026, to 1617.

ZOMDF Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zomedica Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZOMDF Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 6.66 % 9.65 % 9.63 % 1.71 % 3 %
Y / Y Cost of Sales Growth 51.04 % 50 % -17.47 % 100 % 129.8 %
Inventory Turnover Ratio (TTM) 2.05 1.87 1.74 1.91 1.73
ZOMDF's Total Ranking # 1617 # 1237 # 1237 # 1237 #
Average inventory processing period 178 195 210 191 211
Seq. Inventory Growth 2.98 % 5.95 % 0.42 % -2.64 % 5.86 %
Seq. Cost of Sales Growth 15.7 % -9.12 % 65.05 % -12.97 % 14.9 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 57
Healthcare Sector # 198
Overall Market # 1617

Inventory Turnover Ratio Statistics
High Average Low
2.05 1.58 0.8
(Jun 30 2026)   (Dec 31 2021)



ZOMDF Company Profile >> Back to ZOMDF Efficiency Comparisons >> Compare ZOMDF Inventory Turnover Ratio to its Competitors

Financial Statements
Zomedica 's Inventories $ 6 Millions Visit ZOMDF's Balance sheet
Zomedica 's Cost of Revenues TTM $ 12 Millions Visit ZOMDF's Income Statement
What are ZOMDF's Sales? Visit ZOMDF's Sales by Segment

Other Inventory Turnover Ratios
Zomedica 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZOMDF's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZOMDF's Competitors
Inventory Turnover Ratio for ZOMDF's Suppliers
Inventory Turnover Ratio for ZOMDF's Customers

You may also want to know
ZOMDF's Sales Growth Rates ZOMDF's Pe Price to earnings ratio ZOMDF's Receivables Turnover Ratio ZOMDF's Stock Quote
ZOMDF's Net Income Growth Rates ZOMDF's Ps Price to Sales ratio ZOMDF's Sales per Employee ZOMDF's Asset Turnover Ratio
ZOMDF's Net Margin ZOMDF's Pb Price to Book ratio ZOMDF's Financial Strength Ratios ZOMDF's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.